Asymmetric Organocatalysis-A Powerful Technology Platform for Academia and Industry: Pregabalin as a Case Study

Secci Francesco
Penultimo
Membro del Collaboration Group
;
2022-01-01

Abstract

Enantioselective organocatalysis has quickly established itself as the third pillar of asymmetric catalysis. It is a powerful technology platform, and it has a tremendous impact in both academic and industrial settings. By focusing on pregabalin, as a case study, this Perspective aims to show how a process amenable to industry of a simple chiral molecule can be tackled in several different ways using organocatalysis.
2022
Inglese
CATALYSTS
12
8
912
923
12
WOS:000847155800001
2-s2.0-85137556139
https://www.mdpi.com/2073-4344/12/8/912/htm
Esperti anonimi
internazionale
scientifica
industry; process development; organocatalysis; pregabalin; API; asymmetric catalysis; catalysis
no
Giorgianni, Giuliana; Bernardi, Luca; Fini, Francesco; Pesciaioli, Fabio; Secci, Francesco; Carlone, Armando
1.2 Recensione in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.2 Recensione in rivista
263
open
6
File in questo prodotto:
File Dimensione Formato  
catalysts-12-00912-v2 (1).pdf

accesso aperto

Tipologia: versione post-print
Dimensione 3.43 MB
Formato Adobe PDF
Visualizza/Apri
3.43 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie